| Name | Title | Contact Details |
|---|---|---|
Ivan Gonzalez |
VP of Quality, Compliance, and Regulatory Affairs | Profile |
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Southern Medical Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A premier senior housing company through ownership and third party management that focuses on maximizing revenue drivers and operational efficiencies by allowing individual resident needs and preferences to drive service offerings and by focusing on resident and employee satisfaction.
Health Plus PHSP Inc is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced ENT and Allergy is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.